Â¥
3.21
Jun 19
New Key Statistics Module, Z-Score and F-Score
SZSE:300026 Key Ratios
Market Cap ¥ M | 9,643.34 |
Enterprise Value ¥ M | 9,734.90 |
P/E(ttm) | 24.69 |
PE Ratio without NRI | 19.11 |
Forward PE Ratio | -- |
Price/Book | 1.10 |
Price/Sales | 1.61 |
Price/Free Cash Flow | 10.04 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.18 |
Revenue (TTM) ¥ M | 5,913.00 |
EPS (TTM) ¥ | 0.13 |
Beneish M-Score | -2.75 |
10-y EBITDA Growth Rate % | 6.00 |
5-y EBITDA Growth Rate % | 17.50 |
y-y EBITDA Growth Rate % | -26.40 |
EV-to-EBIT | 18.39 |
EV-to-EBITDA | 18.39 |
PEG | 1.09 |
Shares Outstanding M | 3,004.15 |
Net Margin (%) | 6.58 |
Operating Margin % | 9.26 |
Pre-tax Margin (%) | 7.94 |
Quick Ratio | 3.01 |
Current Ratio | 4.14 |
ROA % (ttm) | 3.18 |
ROE % (ttm) | 4.51 |
ROIC % (ttm) | 4.71 |
Dividend Yield % | 0.94 |
Altman Z-Score | 3.64 |
SZSE:300026 Number of Guru Trades
SZSE:300026 Volume of Guru Trades
Gurus Latest Trades with SZSE:300026
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300026 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Tianjin Chase Sun Pharmaceutical Co Ltd Insider Transactions
No Available Data